Guest guest Posted February 19, 2008 Report Share Posted February 19, 2008 Hi, all. Here's a hypothesis that may explain at least some cases of MCS. I think it can explain why Prof. Marty Pall and Dr. Grace Ziem have had good results with nebulized glutathione and even glutathione nasal spray. It can also explain why people with MCS are sensitive to a whole variety of chemicals, and why symptoms appear so rapidly when they are exposed to chemicals in the gaseous state (volatile chemicals). Furthermore, I think it can explain why MCS is often associated with CFS. Here it is: In the olfactory epithelium in the nose, there are olfactory neurons and sustentacular (supporting) cells. The sustentacular cells have been found to contain CYP450 enzymes at even higher concentration than the liver. I suspect that their role is to break down chemicals that are inhaled and that dissolve in the mucus overlaying the olfactory epithelium, i.e. to perform Phase I detox on these chemicals, just as this enzyme system does in the liver. It is known that CYP450 enzymes generate superoxide ions, and that glutathione is necessary to deal with the resulting hydrogen peroxide from the superoxide dismutase reactions. If glutathione is depleted in the sustentacular cells, I think we can expect not only the buildup of reactive oxygen species, but also the survival of chemicals that would normally be detoxed and removed, either in their unreacted states or in their Phase I biotransformed states, which in some cases are more toxic. This combination could be expected to produce damage to cell membranes (both sustentacular cells and olfactory neurons), due to the oxidative stress, and this would allow entry of toxic chemicals into the olfactory neurons. From there, they have a short path to the brain, and voila: MCS. If this model is valid, it would seem that lifting the methylation cycle block and thus allowing glutathione levels to come up to normal would correct MCS along with correcting CFS. I don't think this model explains why a large fraction of the people with MCS can trace their onset to an acute high exposure to some volatile chemical. This apparently caused damage that was not repaired, presumably to a barrier in the olfactory epithelium that normally prevents chemicals from entering the brain via the olfactory epithelium. I don't understand this yet. I think this model can account for the cases of MCS that did not start with an acute exposure, howeever, and especially cases that are associated with CFS, which in many cases seems to be associated biochemically with a methylation cycle block. I would appreciate comments on whether you think this model fits. Thanks. Rich Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.